Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

US IVIG market gets a new player (Biotest AG):

http://finance.yahoo.com/news/fda-approves-biotests-bivigam-intravenous-163000163.html

Biotest AG announced today that Biotest Pharmaceuticals Corporation received approval for BIVIGAM for the treatment of patients with Primary Humoral Immunodeficiency (PI) from the U.S. Food and Drug Administration.

…The U.S. IVIG market is the largest in the world and Biotest's entry into this market fulfills the company's longstanding vision of being a significant global participant. Biotest formed BPC as a U.S. subsidiary in 2007, with the purchase of Nabi Biopharmaceuticals' biologics strategic business unit, which included a plasma protein plant and plasma collection centers.